Atlas Trials

Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD)

RecordFirmDate
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis (NCT01383759)Memorial Sloan Kettering Cancer Center2011-06-24

Track Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) automatically

Every clearance here is in the API, with alerts when new ones post.